La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Alzheimer Disease (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Alzheimer Disease (immunology) < Alzheimer Disease (metabolism) < Alzheimer Disease (mortality)  Facettes :

List of bibliographic references indexed by Alzheimer Disease (metabolism)

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000332 (2016) Sheela Vyas [France] ; Ana João Rodrigues [Portugal] ; Joana Margarida Silva [Portugal] ; Francois Tronche [France] ; Osborne F. X. Almeida [Allemagne] ; Nuno Sousa [Portugal] ; Ioannis Sotiropoulos [Portugal]Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration
000594 (2015) Ling Shan [États-Unis] ; Yves Dauvilliers [France] ; Jerome M. Siegel [États-Unis]Interactions of the histamine and hypocretin systems in CNS disorders.
000A34 (2014) Mauricio G. Martín [Argentine] ; Frank Pfrieger [France] ; Carlos G. Dotti [Espagne]Cholesterol in brain disease: sometimes determinant and frequently implicated
001129 (2012) Ismael Galván [France] ; Ghanem Ghanem ; Anders P. M LlerHas removal of excess cysteine led to the evolution of pheomelanin? Pheomelanogenesis as an excretory mechanism for cysteine.
001176 (2012) Marie-Hélène Canron [France] ; Martine Perret [France] ; Anne Vital [France] ; Erwan Bézard [France] ; Benjamin Dehay [France]Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate
001525 (2011) Guylaine Hoffner [France] ; Amandine Vanhoutteghem ; William André ; Philippe DjianTransglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.
002287 (2008) Bruno Vincent [France] ; Moustapha Alfa Cisse ; Claire Sunyach ; Marie-Victoire Guillot-Sestier ; Frédéric CheclerRegulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
002B32 (2006) V. Deramecourt [France] ; S. Bombois [France] ; C.-A. Maurage [France] ; A. Ghestem [France] ; H. Drobecq [France] ; E. Vanmechelen [Belgique] ; F. Lebert [France] ; F. Pasquier [France] ; A. Delacourte [France]Biochemical staging of synucleinopathy and amyloid deposition in dementia with lewy bodies
002B65 (2005) Guylaine Hoffner [France] ; Philippe DjianTransglutaminase and diseases of the central nervous system.
003244 (2003) Jose-Luis Gonzalez De Aguilar [France] ; Frédérique Rene [France] ; Luc Dupuis [France] ; Jean-Philippe Loeffler [France]Neuroendocrinology of neurodegenerative diseases: Insights from transgenic mouse models
003889 (2000) C B Lücking [France] ; A. BriceAlpha-synuclein and Parkinson's disease.
003B92 (2000) Pierre Dubus [France] ; Baptiste Faucheux [France] ; Florence Boissiere [France] ; Alexis Groppi [France] ; Claude Vital [France] ; T. Anne Vital [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Philippe Merlio [France]Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease
003E34 (1999) Luc Buée [France] ; André Delacourte [France]Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease
004938 (1994) A. Delacourte [France]Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration
004A06 (1994) Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
004C53 (1993) A. Kastner [France] ; E. C. Hirsch ; M. T. Herrero ; F. Javoy-Agid ; Yves Agid [France]Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease
005009 (1990) I. Ceballos [France] ; F. Javoy-Agid ; A. Delacourte ; A. Defossez ; A. Nicole ; P M SinetParkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency?
005075 (1990) Roger Deloncle [France] ; Olivier Guillard [France]Mechanism of Alzheimer's disease: Arguments for a neurotransmitter-aluminium complex implication
005096 (1990) M. Ruberg [France] ; W. Mayo [France] ; A. Brice [France] ; C. Duyckaerts [France] ; J. J Hauw [France] ; H. Simon [France] ; M. Lemoal [France] ; Yves Agid [France]Choline acetyltransferase activity and [ 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions
005916 (????) Stéphane Martin [France][Extranuclear functions of protein sumoylation in the central nervous system].
005958 (????) J L Mege [France] ; C. Capo ; B. Michel ; J L Gastaut ; P. BongrandPhagocytic cell function in aged subjects.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Alzheimer Disease (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Alzheimer Disease (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Alzheimer Disease (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024